Seattle Genetics (SGEN) PT Increases to $95 at Piper Jaffray

September 30, 2019 9:12 AM EDT Send to a Friend
Piper Jaffray analyst Joseph Catanzaro reiterated an Overweight rating and raised the price target to $95.00 on Seattle Genetics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login